These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 18309033)

  • 1. Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents.
    Crowther MA; Warkentin TE
    Blood; 2008 May; 111(10):4871-9. PubMed ID: 18309033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing bleeding in anticoagulated patients with a focus on novel therapeutic agents.
    Crowther MA; Warkentin TE
    J Thromb Haemost; 2009 Jul; 7 Suppl 1():107-10. PubMed ID: 19630780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bleeding complications of anticoagulant therapy].
    Gumulec J; Kessler P; Procházka V; Brejcha M; Penka M; Zänger M; Machytka E; Klement P
    Vnitr Lek; 2009 Mar; 55(3):277-89. PubMed ID: 19378860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of bleeding complications in patients on anticoagulant therapy.
    Piran S; Schulman S
    Blood; 2019 Jan; 133(5):425-435. PubMed ID: 30559261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
    Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific antidotes in development for reversal of novel anticoagulants: a review.
    Gomez-Outes A; Suarez-Gea ML; Lecumberri R; Terleira-Fernandez AI; Vargas-Castrillon E
    Recent Pat Cardiovasc Drug Discov; 2014; 9(1):2-10. PubMed ID: 25494843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversing anticoagulants both old and new.
    Warkentin TE; Crowther MA
    Can J Anaesth; 2002; 49(6):S11-25. PubMed ID: 12557411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of thrombotic and cardiovascular disorders in the new millenium.
    Fareed J; Hoppensteadt DA; Bick RL
    Clin Appl Thromb Hemost; 2003 Apr; 9(2):101-8. PubMed ID: 12812377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approaches to prevent bleeding associated with anticoagulants: current status and recent developments.
    Kalathottukaren MT; Haynes CA; Kizhakkedathu JN
    Drug Deliv Transl Res; 2018 Aug; 8(4):928-944. PubMed ID: 28741113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of Anticoagulation and Management of Bleeding in Patients on Anticoagulants.
    Dhakal P; Rayamajhi S; Verma V; Gundabolu K; Bhatt VR
    Clin Appl Thromb Hemost; 2017 Jul; 23(5):410-415. PubMed ID: 27789605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation: the present and future.
    Van Aken H; Bode C; Darius H; Diehm C; Encke A; Gulba DC; Haas S; Hacke W; Puhl W; Quante M; Riess H; Scharf R; Schellong S; Schrör T; Schulte KL; Tebbe U
    Clin Appl Thromb Hemost; 2001 Jul; 7(3):195-204. PubMed ID: 11441979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reversal for heparins and new anticoagulant treatments].
    Kortchinsky T; Vigué B; Samama CM
    Ann Fr Anesth Reanim; 2013 Jan; 32(1):37-49. PubMed ID: 23273505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic approach to the bleeding in association with "old" and "new" anticoagulants].
    Dulíček P
    Vnitr Lek; 2012; 58(7-8):559-63. PubMed ID: 23067175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [-Anticoagulant drugs-].
    Gulba DC
    Herz; 1996 Feb; 21(1):12-27. PubMed ID: 8647576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Old versus new anticoagulants: focus on pharmacology.
    Benmira S; Banda ZK; Bhattacharya V
    Recent Pat Cardiovasc Drug Discov; 2010 Jun; 5(2):120-37. PubMed ID: 20337579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversing anticoagulant therapy.
    Ghanny S; Warkentin TE; Crowther MA
    Curr Drug Discov Technol; 2012 Jun; 9(2):143-9. PubMed ID: 22023256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulation for acute coronary syndromes: from heparin to direct thrombin inhibitors.
    Lepor NE
    Rev Cardiovasc Med; 2007; 8 Suppl 3():S9-17. PubMed ID: 17917621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct inhibitors of coagulation proteins - the end of the heparin and low-molecular-weight heparin era for anticoagulant therapy?
    Laux V; Perzborn E; Heitmeier S; von Degenfeld G; Dittrich-Wengenroth E; Buchmüller A; Gerdes C; Misselwitz F
    Thromb Haemost; 2009 Nov; 102(5):892-9. PubMed ID: 19888525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venographic comparison of subcutaneous low-molecular weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis.
    Gonzalez-Fajardo JA; Arreba E; Castrodeza J; Perez JL; Fernandez L; Agundez I; Mateo AM; Carrera S; Gutiérrez V; Vaquero C
    J Vasc Surg; 1999 Aug; 30(2):283-92. PubMed ID: 10436448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.